Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PHAXIAM THERAPEUTICS | 71,839 | net | 23 Jun 2023 | tx 1+71,839 |
| KALRAY | -2,200 | net | 27 Apr 2026 | tx 2+4,500−6,700 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Apr 2026 | SALE | KALRAY | 6,700 | 10.11 EUR | |
| 20 Sept 2024 | PURCHASE | KALRAY | 4,500 | 2.31 EUR | first after silence |
| 23 Jun 2023 | PURCHASE | PHAXIAM THERAPEUTICS | 71,839 | 0.61 EUR |
1 purchase reported after at least 12 months of silence — most recent on 20 Sept 2024.